Cargando…

P1721: PROGNOSTIC FACTORS IN PATIENTS IN THE TERMINAL PHASE OF HEMATOLOGICAL MALIGNANCIES WHO RECEIVED HOME MEDICAL CARE

Detalles Bibliográficos
Autores principales:	Miyashita, N., Onozawa, M., Fujita, M., Hosoda, T., Kawasaki, Y., Takimoto, M., Okina, S., Ohashi, K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429177/ http://dx.doi.org/10.1097/01.HS9.0000849740.33271.19

Ejemplares similares

The music and history of the Baroque trumpet before 1721 /
por: Smithers, Don L., 1933-
Publicado: (1988)

An Eighteenth-century surgeon and apothecary: William Elmhirst (1721-1773).
por: Sigsworth, E M, et al.
Publicado: (1982)

Potent Anticancer Effects of Epidithiodiketopiperazine NT1721 in Cutaneous T Cell Lymphoma
por: Lin, Min, et al.
Publicado: (2021)

Attenuation of hedgehog/GLI signaling by NT1721 extends survival in pancreatic cancer
por: Kowolik, Claudia M., et al.
Publicado: (2019)

1721. An Outbreak of Botulism Associated With Nacho Cheese Sauce From a Gas Station in California
por: Rosen, Hilary, et al.
Publicado: (2018)

NT1721, a novel epidithiodiketopiperazine, exhibits potent in vitro and in vivo efficacy against acute myeloid leukemia
por: Kowolik, Claudia M., et al.
Publicado: (2016)

1721. A Transcriptional Signature of Acute Aspergillus Infection Offers High Diagnostic Accuracy Despite the Presence of Immunosuppression
por: Steinbrink, Julie M, et al.
Publicado: (2019)

PB1721: CD27 EXPRESSION IN CHILDREN WITH B CELL LYMPHOID MALIGNANCIES AND HEMOPHAGOCYTIC LYMPH HISTIOCYTOSIS IN RELATION TO EBV STATUS: A PILOT STUDY
por: Hussien, Nihal, et al.
Publicado: (2023)

Home Care of Terminal Malignant Disease
por: Gibson, Ronald
Publicado: (1971)

Regulatory T Cells and Their Prognostic Relevance in Hematologic Malignancies
por: D'Arena, Giovanni, et al.
Publicado: (2017)

The incidence of thrombocytopenia in adult patients receiving chemotherapy for solid tumors or hematologic malignancies
por: Shaw, Jaime L., et al.
Publicado: (2021)

Serum voriconazole level variability in patients with hematological malignancies receiving voriconazole therapy
por: Saini, Lalit, et al.
Publicado: (2014)

1721P Prolonged positive SARS-CoV-2 RT-PCR in cancer outpatients requires specific reorganization of cancer centres
por: Aguinaga, L., et al.
Publicado: (2020)

Arzneimittel in der Therapie Friedrich Hoffmanns (1660–1742) unter besonderer Berücksichtigung der Medicina Consultatoria (1721–1723)
por: Maehle, Andreas-Holger
Publicado: (1998)

1721. BCG Vaccination Impact on Mortality: a 71 year Follow-up of a US BCG Controlled Trial
por: Costello, Varea H, et al.
Publicado: (2023)

Correction: Lin et al. Potent Anticancer Effects of Epidithiodiketopiperazine NT1721 in Cutaneous T Cell Lymphoma. Cancers 2021, 13, 3367
por: Lin, Min, et al.
Publicado: (2021)

Microsatellite instability in hematological malignancies: Hypermutation vs. immune control—who is challenging who?
por: Maletzki, Claudia, et al.
Publicado: (2013)

CD markers polymorphisms as prognostic biomarkers in hematological malignancies
por: Shahrabi, Saeid, et al.
Publicado: (2020)

Prognostic significance of isochromosome 17q in hematologic malignancies
por: Koczkodaj, Dorota, et al.
Publicado: (2021)

New Clues to Prognostic Biomarkers of Four Hematological Malignancies
por: Salifu, Samson Pandam, et al.
Publicado: (2022)

Outcomes and Prognostic Factors in Critical Patients with Hematologic Malignancies
por: Chen, Chieh-Lung, et al.
Publicado: (2023)

Prognostic factors for mortality with fungal blood stream infections in patients with hematological and non-hematological malignancies
por: Salih, Zena, et al.
Publicado: (2013)

Addendum: Prognostic significance of isochromosome 17q in hematologic malignancies
por: Koczkodaj, Dorota, et al.
Publicado: (2023)

Should Physicians Be Permitted to Refuse Follow-Up Care to Patients Who Have Received an Organ Transplant Through Organ Trafficking?
por: Takimoto, Yoshiyuki
Publicado: (2023)

Caregivers of Patients with Hematological Malignancies within Home Care: A Phenomenological Study
por: Capodanno, Isabella, et al.
Publicado: (2020)

Checkpoint inhibition in hematologic malignancies
por: Tsumura, Aaron, et al.
Publicado: (2023)

The treatment of hematologic malignancies in pregnancy
por: Vandenbriele, C., et al.
Publicado: (2010)

RECQ helicases are deregulated in hematological malignancies in association with a prognostic value
por: Viziteu, Elena, et al.
Publicado: (2016)

The prognostic factors for patients with hematological malignancies admitted to the intensive care unit
por: Cheng, Qian, et al.
Publicado: (2016)

Microbiology and prognostic prediction model of bloodstream infection in patients with hematological malignancies
por: Wang, Jinjin, et al.
Publicado: (2023)

Clinical Efficacy and Safety of Arbekacin against Pneumonia in Febrile Neutropenia: A Retrospective Study in Patients with Hematologic Malignancies
por: Ohashi, Takashi, et al.
Publicado: (2022)

Oncolytic Virotherapy for Hematological Malignancies
por: Bais, Swarna, et al.
Publicado: (2012)

Malignant Pleural Mesothelioma in Patients Who Previously Received Radiotherapy for Their First Malignant Tumor
por: Sekine, Ikuo, et al.
Publicado: (2020)

Breakthrough Bacteremia with Meropenem-resistant Pseudomonas aeruginosa in Hematologic Malignancy Patients Receiving Levofloxacin Prophylaxis
por: Hakki, Morgan, et al.
Publicado: (2017)

415. Breakthrough Invasive Fungal Infections in Adult Hematologic Malignancy Patients Receiving Isavuconazole Prophylaxis
por: DeVoe, Catherine, et al.
Publicado: (2018)

2678. Characterizing Hospitalizations and Infections Among Older Adults Receiving Palliative Chemotherapy for Hematologic Malignancies
por: Uy, Natalie, et al.
Publicado: (2019)

Anticoagulant and Anti-thrombotic Treatments in the Management of Hematological Malignancies in a Home Care Program
por: Tendas, Andrea, et al.
Publicado: (2011)

Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies
por: Einsele, Hermann, et al.
Publicado: (2020)

Vorinostat in solid and hematologic malignancies
por: Siegel, David, et al.
Publicado: (2009)

Carbamazepine and Hematological Malignancies
por: Yavaşoğlu, İrfan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_agmtpkecenod3usjitr1h2tlug